修改地中海饮食对帕金森病的影响 (MED-PARK):单中心随机对照试验协议
Elenamaria Pirovano1, Franca Marino2, Elena Rossi1
1Center for Research in Medical Pharmacology, University of Insubria, Varese, VA, Italy.
BMJ open
|October 5, 2025
概括
这项研究调查了修改后的地中海饮食是否可以改善帕金森病患者的症状. 研究人员将在六个月内评估饮食对运动和非运动症状,免疫功能和肠道健康的影响.
科学领域:
- 神经学 神经学
- 营养科学 营养科学
- 免疫学 免疫学 免疫学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,目前只有症状治疗方法可用.
- 流行病学研究表明,地中海饮食可以改善PD症状并减缓疾病的进展.
- 探索饮食在PD严重程度和进展中的作用的干预性研究是有限的.
研究的目的:
- 为了确定修改的地中海饮食干预措施是否有利于PD患者的运动和非运动症状.
- 评估修改地中海饮食对免疫系统,新陈代谢和微生物组的二次影响.
- 评估对帕金森病的非药物营养干预措施的安全性和有效性.
主要方法:
- 一项为期6个月的随机对照试验,涉及44名PD患者 (40-85岁).
- 参与者被分配到他们通常的饮食 (控制) 或经过修改的地中海饮食 (干预).
- 主要结果:运动障碍学会统一帕金森病评分表 (MDS-UPDRS) I+II分数. 二级结局包括免疫细胞概况,微生物组和代谢标记.
主要成果:
- 数据收集和分析正在进行中.
- 这项研究旨在提供有关饮食干预措施对PD症状学影响的见解.
- 结果将在研究完成后传播.
结论:
- 这项研究将提供关键证据,证明修改后的地中海饮食作为帕金森病疾病修改策略的潜力.
- 结果可能会为未来的营养指南和PD管理的治疗方法提供信息.
- 这项研究有助于了解饮食对PD所影响的复杂生物系统的影响.
更多相关视频
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
11.1K
09:19Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
26.2K
相关概念视频
01:24Parkinson's Disease: Treatment
983
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
983
01:15Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
143
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
143